CIDRAP newsletters options
South Africa has reported more highly pathogenic H5N8 detections in ostriches, other captive birds, and a wild bird, and Cambodia reported another H5N1 outbreak in poultry, according to the latest avian flu reports from the World Organization for Animal Health (OIE).
Texas researchers who analyzed data from 230 US hospitals discovered that patients with a urine culture taken on the day of hospital admission receive more days of antibiotics and have a longer hospital stay than do patients who do not have a urine culture, according to their study yesterday in Infection Control and Hospital Epidemiology (ICHE).
Death rates dropped 18.7% from 1980 to 2014, with the largest decline in men.
The findings represent an opportunity to reduce unnecessary use of the drugs.
The pace of new infections in Nigeria's Lassa fever outbreak is starting to slow, but the epidemic is far from contained, the World Health Organization (WHO) and the Nigeria Centre for Disease Control (NCDC) said yesterday in a statement.
Overall global antibiotic use climbed by 65% from 2000 through 2015.
Of kids 7 years and older with autism, 82% got recommended vaccines by age 4, compared with 94% in those without autism.
The Saudi Arabian Ministry of Health (MOH) released four new reports of MERS-CoV cases over the weekend, including two cases that had direct contact with camels.
On Mar 21, a 67-year-old Saudi man from Najran was diagnosed as having MERS-CoV (Middle East respiratory syndrome coronavirus). He is in stable condition and had contact with camels.
A survey of 244 members of three infectious diseases societies reveals that the most common approached to antimicrobial stewardship programs (ASPs) are antibiotic reviews with prospective audit and feedback (PAF), prior authorization for select antibiotics, and guideline development, according to a study today in Clinical Infectious Diseases.
Illnesses from Salmonella Javiana, Thompson, and Infantis have risen about 50% in 10 years.
Nearly a third of hospitalized children get drugs to prevent, not treat, bacterial infections.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
A 9-year single-center study by Columbia University scientists published yesterday in Infection Control & Hospital Epidemiology found that decreases in multidrug-resistant organisms (MDROs) were likely not due to implementing universal contact precautions (UCPs).
The rate of outpatient visits for influenza-like illnesses (ILI) dropped to 2.7% last week, close to the national baseline of 2.2%, according to the latest influenza surveillance data collected by the Centers for Disease Control and Prevention (CDC). This is the 17th week ILI has been at or above the national baseline.
The move is praised by some experts, but Redfield comes with a controversial past.
Resistance adds nearly $1,400 to the bill for treating a bacterial infection in the US.
The $1.3 trillion omnibus spending bill passed by the US House of Representatives today to fund the government through the end of September contains increases for the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC), according to official and media sources.
In a first for a Japanese company, CARB-X, a public-private collaboration that supports companies to combat antimicrobial resistance, has awarded Shionogi, of Osaka, $4.7 million to support the development of a novel beta-lactam antibiotic with potent activity against the worrisome superbugs that produce carbapenemase, including BL/BLI-resistant carbapenem-resistant Enterobacteriaceae (CRE), CARB-X said in a news release today.
Three of 13 patients have been hospitalized, and recalled products include those from Natural Grocers and International Harvest, Inc.
The vaccination campaign will aim to reach 78 million Brazilians by 2019.
